The Traderszone Network

Published in TZ Latest News 1 August, 2014 by The TZ Newswire Staff

Biotech Gets A Lift On Popular Drug, Strong Pipeline

The success of Biogen Idec’s (BIIB) oral multiple sclerosis (MS) treatment Tecfidera has been well documented in recent quarters, but the company is far from a one-hit wonder.

Its biggest seller is Avonex, an injectable MS treatment.

read more